Survival patterns for malignant mesothelioma: The seer experience
The DOI matches its Crossref record.
Abstract
Statistical analyses of 1,475 histologically confirmed cases of malignant mesothelioma ascertained through the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute for the years 1973‐1984 showed age at diagnosis, sex, stage of disease, type of treatment, and geographic area of residence to be important predictors of patient survival, although type of treatment may be confounded with prognostic factors (patients selected for surgical treatment tended to have better performance status than other patients). Women below the age of 50 had an unusually long survival, even after adjustment for the effects of other variables in the model. A relatively large proportion of female cases had site of disease designated as peritoneum, but site was not a significant prognostic factor. These results suggest that age, gender and stage of disease should be carefully considered in designing and analyzing clinical trials for persons with mesothelioma. Survival was shorter in the 4 SEER registries which had shipbuilding as a major industry than in the others with less potential asbestos exposure, offering weak support for the hypothesis that asbestos‐exposed cases of mesothelioma have worse survival experience than other cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Scherpereel, A., Astoul, P., Baas, P., Berghmans, T., Clayson, H., de Vuyst, P., Dienemann, H., Galateau-Salle, F., Hennequin, C., Hillerdal, G., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00063109 · Cited by 638
A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma
(1995) · Chest · doi:10.1378/chest.108.4.1122 · Cited by 606
Curran, D., Sahmoud, T., Therasse, P., van Meerbeeck, J., Postmus, P. E., & Giaccone, G. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.145 · Cited by 543
Herndon, J. E., Green, M. R., Chahinian, A. P., Corson, J. M., Suzuki, Y., & Vogelzang, N. J. (1998) · Chest · doi:10.1378/chest.113.3.723 · Cited by 504
Kao, S. C. H., Pavlakis, N., Harvie, R., Vardy, J. L., Boyer, M. J., van Zandwijk, N., & Clarke, S. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2245 · Cited by 316
Kidd, A. C., McGettrick, M., Tsim, S., Halligan, D. L., Bylesjo, M., & Blyth, K. G. (2018) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000240 · Cited by 206
“We did not select Hb as a potential candidate predictor for the current study because the prognostic impact of Hb levels had been contradictory in MPM studies which have reported negative,(33) positive(34) and no prognostic association with thrombocytosis.(35) In the current study, integrated measures of systemic infl…”
ResultMeyerhoff, R. R., Yang, C.-F. J., Speicher, P. J., Gulack, B. C., Hartwig, M. G., D'Amico, T. A., Harpole, D. H., & Berry, M. F. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.01.043 · Cited by 199
Marinaccio, A., Montanaro, F., Mastrantonio, M., Uccelli, R., Altavista, P., Nesti, M., Costantini, A. S., & Gorini, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.20820 · Cited by 123
Metadata
- Authors
- Spirtas, R., Connelly, R. R., & Tucker, M. A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1988-04-15
- Volume
- 41
- Issue
- 4
- Pages
- 525-530
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2034379492
- Cited by
- 123
- References
- 0
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.